Previous Close | 16.57 |
1-Year Change | -15.89% |
6-Months Change | -28.98% |
3-Months Change | -8.55% |
Moving Avg (50d) | 16.736 |
Moving Avg (200d) | 20.236 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 0.769B |
Beta (3-Years) | 0.96 |
Revenue Growth (ttm) | 15.79% |
Net Profit Margin (ttm) | -6.52% |
Return On Assets (ttm) | -3.21% |
EPS (ttm) | -1.19 |
PE Ratio (ttm) | -13.92 |
Dividend Yield | % |
Asset Description: | Avanos Medical, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2025-02-03 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
16.901 | 17.398 | 17.73 | 18.227 | 19.055 | 19.884 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Technology |
Country: | United States |